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ABSTRACT: Microscopy-based high-content and high-
throughput analysis of cellular systems plays a central role in
drug discovery. However, for contrast and speciﬁcity, the
majority of assays require a ﬂuorescent readout which always
comes with the risk of alteration of the true biological
conditions. In this work, we demonstrate a label-free imaging
platform which combines chemically speciﬁc hyperspectral
coherent anti-Stokes Raman scattering microscopy with sparse
sampling and Bessel beam illumination. This enabled us to
screen multiwell plates at high speed, while retaining the high-
content chemical analysis of hyperspectral imaging. To
demonstrate the practical applicability of the method we addressed a critical side eﬀect in drug screens, namely, drug-induced
lipid storage within hepatic tissue. We screened 15 combinations of drugs and neutral lipids added to human HepG2 liver cells
and developed a high-content quantitative data analysis pipeline which extracted the spectra and spatial distributions of lipid and
protein components. We then used their combination to train a support vector machine discriminative algorithm. Classiﬁcation
of the drug responses in terms of phospholipidosis versus steatosis was achieved in a completely label-free assay.
For many years high-throughput high-content microscopyhas played a central role in the discovery and development
of therapeutics through the screening of phenotypes.1 Imaging
screens are not only able to deﬁne positive phenotypes but also
indicate potential unwanted side-eﬀects. To develop contrast
within the specimen, the majority of high-content assays
require modiﬁcation of the biological system with a ﬂuorescent
readout.2,3 While inclusion of a ﬂuorescent reporter is a
powerful technique, it precludes the use of unmodiﬁed primary
tissues and cell types and always incorporates the risk of
alteration of the true biological conditions of the system under
test. In addition, multiplexing of ﬂuorescent readouts is
typically limited to a small number that can be well separated
by optical ﬁlters.3
An example of a critical side eﬀect that needs to be assessed
in drug screens and is speciﬁcally hard to detect in current
ﬂuorescent-based assays is drug-induced lipid storage within
hepatic tissue. The liver plays a central role in the detoxiﬁcation
of foreign molecules and drugs and, thus, is particularly
susceptible to drug induced injury. The onset of toxicity within
hepatic tissue has led to the cancelation of clinical trials, and is
the greatest cause of the withdrawal of commercially available
therapeutics following approval.4,5 Drug-induced liver injury
(DILI) includes steatosis and phospholipidosis, which involve
the production of cellular structures containing excess lipid.
Drug-induced steatosis (DIS) is the accumulation of lipids in
the form of diacyl and triacylglycerols within intracellular lipid
droplets with a phospholipid monolayer surrounding the lipid
core, and is often caused by an oﬀ-target eﬀect of the drug that
results in mitochondrial damage.6 Phospholipidosis is the
accumulation of phospholipid membranes within a multi-
layered/multilamellar structure. Because of the potential for
drug induced lipid storage to (a) prevent the development and
progress of drugs into the clinic and (b) to lead to the
development of potentially life threatening side eﬀects once
administered, it is important to not only detect the onset of
these problems as early as possible within the development
cycle but also clearly deﬁne which lipid storage phenotype is
prevalent.
End point assays are available for both phospholipidosis and
steatosis; however, the addition of ﬂuorescent components has
major limitations since lipid-binding dyes photobleach severely
and may aﬀect development. The gold standard of deﬁning
phospholipidosis is the use of electron microscopy to identify
lipid rich cellular structures with a morphology resembling an
onion, which is laborious and time-consuming. What is
required is a label-free noninvasive method that is capable of
detecting the presence of, and the diﬀerence between
phospholipidosis and steatosis, yet is fast and amenable to
Received: October 2, 2017
Accepted: March 5, 2018
Published: March 5, 2018
Article
pubs.acs.org/acCite This: Anal. Chem. 2018, 90, 3775−3785
© 2018 American Chemical Society 3775 DOI: 10.1021/acs.analchem.7b04039
Anal. Chem. 2018, 90, 3775−3785
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,
provided the author and source are cited.
high-throughput methods, ideally applicable to living cells so
that the progress of drug induced eﬀects can be monitored over
time. Importantly, the development of a readout that can track
the progress of DILI would also provide a tool allowing the
screening of therapeutic treatments of DIS, which is a current
unmet need within the ﬁeld.7
Coherent Raman scattering (CRS) microscopy has emerged
in the last two decades as a powerful label-free chemically
speciﬁc multiphoton microscopy technique.8 In Raman
scattering, the interaction of light with vibrating chemical
bonds gives rise to light at a diﬀerent wavelength compared to
the incident ﬁeld. The wavelength shift is a direct signature of
the frequency of the vibration which in turn depends on the
type of chemical bond. This scattering phenomenon usually
produces a very weak signal, but can be strongly enhanced in
CRS when two short laser pulses (denoted as pump and Stokes
of optical frequencies ωp and ωs respectively) are used to
coherently drive the vibrations at frequency ωp−ωs, such that
Raman scattered light from coherently driven molecular
vibrations in the focal volume constructively interferes.
Chemically speciﬁc label-free CRS imaging of living cells with
high spatial and temporal resolution has been demonstrated on
many biological samples, with particular emphasis on imaging
lipids owing to the large number of identical CH bonds in their
Figure 1. (a) Sketch of the optical setup. To switch between Gaussian and Bessel beam excitation, an aperture, an axicon, and a lens are inserted into
the parallel beam path in front of the galvo scanner, prior to entering the optics (scan lens, prism, tube lens, objective) of a commercial inverted
microscope. The axicon with about 4 mrad deﬂection angle generates a ﬁnite Bessel-beam of 250 mm extension for a 1 mm radius input beam
determined by the aperture. The resulting lateral intensity distributions are shown in the central plane of the Bessel beam after the axicon, at the
galvo-scanner, in the intermediate image plane, and at the objective back focal plane, on a color scale as given. The graph shows the axial intensity
distribution, for 10 mW beam power at the sample. b,c) Comparison between hyperspectral CARS imaging acquired with Bessel and Gaussian beam
excitation on a polystyrene bead of 1 μm nominal size in agar. Retrieved concentration maps (xy focal plane and xz equatorial-axial) of polystyrene
(vol/vol) are shown in panel b. Corresponding line cuts and spectral proﬁles of the CARS susceptibility imaginary part (dashed lines) and spectrally
averaged real part (dotted lines) are shown in panel c. Solid lines show the spectra after subtracting the water component. Acquisition settings: 0.122
μm lateral pixel size, 21 axial steps with 0.66 μm step size, 5 cm−1 wavenumber step size, 0.1 ms pixel dwell time. Dry objective 20× 0.75NA, 1× tube
lens. Pump (Stokes) power at the sample was 58 mW (33 mW) for Bessel beam excitation and 11 mW (7 mW) for Gaussian beam excitation.
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acyl chains.8,9 Initial demonstrations of CRS microscopy
focused on showing high-speed imaging up to video rate but
with limited chemical information provided solely from
detecting at a single CH-stretch vibrational resonance and
unable to give a quantitative chemical map of the lipid
concentration.10,11 Subsequent implementations of multiplex or
hyperspectral CRS imaging, where a vibrational spectrum is
measured for each spatial point, enabled much higher
speciﬁcity12 and quantitative spatiotemporal chemical proﬁl-
ing.13 Notably, substantial progress has been made in the
quantitative data analysis associated with hyperspectral imaging
when using coherent anti-Stokes Raman scattering (CARS)
acquisition. The ability to measure the vibrationally non-
resonant part of the third order susceptibility in CARS enables
straightforward in situ calibration via ratiometric comparison
with a standard nonresonant medium in the sample (e.g., water
or the glass coverslip), which in turn results in the quantitative
retrieval of susceptibility spectra factorized into several chemical
components with physically meaningful units.13−15
CARS hyperspectral microscopy appears, therefore, as a
promising tool for quantitative high-content noninvasive
imaging screens, especially in relation to drug induced lipid
storage, however its implementation in a high-throughput
multiwell format has not yet been demonstrated. In this work,
we have developed a novel CARS imaging platform which
combines a Bessel beam illumination, to extend the axial depth
of ﬁeld, with a hyperspectral sparse sampling approach. This
enables screening multiwell plates at high speed (here a 45-fold
improvement compared to Gaussian beam illumination and full
spectral and spatial acquisition) while retaining the high-
content chemical analysis of hyperspectral imaging. To
demonstrate the practical applicability of the method, we
screened 15 combinations of drugs and neutral lipids added to
human HepG2 liver cells. By combining the spatial and spectral
information on the chemical components extracted from the
quantitative data analysis, we were able to train a support vector
machine (SVM) discriminative algorithm and classify the drug
responses in terms of neutral lipid accumulation versus
phospholipidosis in a completely label-free assay.
■ MATERIALS AND METHODS
Microscope Setup. The microscope was built around an
inverted Nikon Ti−U stand as described in ref 16. To switch
between Gaussian and Bessel beam excitation, an aperture, an
axicon, and a lens were inserted into the parallel input beam
path in front of the galvo scanner, as shown in Figure 1,
mounted on two ﬂip mirrors for fast and simple exchange from
Bessel to Gaussian beams. The axicon is made of fused silica
with a tip angle of 179° (Thorlabs AX2505-B) and generates a
conical wavefront with about 4 mrad deﬂection angle, providing
a ﬁnite Bessel-beam of 250 mm extension for a 1 mm radius
input beam determined by the added input aperture (Thorlabs
SM1D12) matching the Gaussian beam waist w0 = 1 mm of the
input beam. Placing the axicon with the tip toward the laser
source avoids the direct back-reﬂection of the collimated beam
by the ﬂat surface, which could aﬀect laser operation. An
achromatic lens (Thorlabs AC254-250-B) with f = 250 mm
focal length is placed at 250 mm distance from the central plane
of the Bessel beam, to image the central plane to inﬁnity. The
lens has a distance of 250 mm from the far-ﬁeld plane at the
galvo scanner, thus imaging the directional space of the Bessel
beam, shown as lateral intensity distribution in Figure 1, into
the far-ﬁeld plane conjugated to the objective back focal plane.
For the chosen elements the ring radius is about 1 mm, similar
to the Gaussian beam and thus compatible with a simple switch
between both beams using the same magniﬁcation to the
objective back focal plane. The scan lens (Nikon) of f = 50 mm
then images the Bessel beam center into the intermediate image
plane, from where it is imaged by the 1× tube lens of focal
length f = 200 mm and the 20× 0.75 NA objective of f = 10 mm
into the sample. Furthermore, since the ﬁll factor for the
Gaussian beam is only 0.55 with the 1× tube lens, by changing
the tube lens to 1.5× we can decrease the axial depth by a factor
(1.5)2 and reduce the lateral PSF width by 1.5, for both
Gaussian and Bessel beams.
In the present work, we do not resolve the CARS signal
directionally and use a wide collection angle (0.72 NA
Condenser). This minimizes the eﬀects of phase matching in
our data. Hyperspectral CARS images were acquired as
described in ref.13,16,17 Brieﬂy, we split the broadband beam
(660−970 nm) from a 5 fs Ti:sapphire laser (Venteon Pulse
One PE) with 80 MHz repetition rate into the pump beam
(660−730 nm) and the Stokes beam (730−900 nm) for CARS
excitation. We use spectral focusing in which an equal linear
chirp is applied to both the pump and Stokes beams, resulting
in a constant instantaneous frequency diﬀerence (IFD), which
can be tuned by varying the delay between pump and Stokes
beams. The resulting pulse duration at the sample is about 1.5
ps, corresponding to an IFD resolution of about 10 cm−1. The
CARS signal is collected by the condenser, separated from the
excitation beams using two Semrock FF01-562/40 ﬁlters and
detected by a photomultiplier (Hamamatsu H7422-40). Data
were typically acquired in the wavenumber range 2600 to 3800
cm−1. Speciﬁc settings for each measurements are indicated in
the captions. Note that our sequential hyperspectral CARS
acquisition with spectral focusing has a typical time per
spectrum of ∼2 ms, given by the time per pixel (10 μs), and
number of spectral point in a spectrum (∼200), which is
comparable to the broadband CARS approaches using a
spectrometer and a CCD camera reported in the literature.18
The microscope stand was also equipped with wide-ﬁeld
diﬀerential interference contrast (DIC) optics and epiﬂuor-
escence illumination and detection, for correlative microscopy.
DIC imaging was performed using a de-Senarmont compensa-
tor with polarizer angle at 12.5 degrees (i.e., a phase oﬀset of 25
degrees). Fluorescence was performed with a metal-halide lamp
at 25% (Lumen L200/D; Prior Scientiﬁc, Rockland, MA) and
an exciter/emitter/dichroic ﬁlter cube GFP-A-Basic (Semrock,
Rochester, NY) for the green channel, and mCherry-40LP-A
(Semrock, Rochester, NY) for the red channel. All images were
acquired at 100 ms frame exposure, except for ﬂuorescence in
the green channel which was acquired at 1 s frame exposure.
Cell Culture. All cell media reagents were purchased from
Invitrogen Life Technologies/ThermoFisher Scientiﬁc (Wal-
tham, MA). Oleic acid and phospholipidosis inducers were
purchased from Sigma (St. Louis, MO). HeLa cells (ATCC
CCL-2) were grown on coverslips or microwell slides
(Hamamatsu A10657-01) in DMEM supplemented with 10%
(v/v) FCS and 2 mM L-glutamine. Fluorescent detection of
phospholipidosis was achieved using LipidTOX Red phospho-
lipid stain according to the manufacturer’s instructions. Brieﬂy,
a 2× stock of phospholipidosis reagent is prepared in growth
media, ﬁlter sterilized, and added to the coverslips in a 6 well
tissue culture dish. To the appropriate wells, an equivalent
volume of growth media containing 2× test compounds is
added. Cells were then incubated for 72 h under standard tissue
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culture conditions. Following the incubation, cells were ﬁxed
with 4% paraformaldehyde in PBS for 20 min, and then washed
with PBS. Fluorescent detection of neutral lipid droplets was
achieved using LipidTOX Green neutral lipid stain according to
the manufacturer’s instructions. Brieﬂy, following PFA ﬁxation
coverslips containing cells were incubated in 1× LipidTOX
green neutral lipid detection solution diluted in PBS for 20 min,
followed by 3 washes in fresh PBS. Coverslips were then
mounted using adhesive imaging spacers (Grace Bio-
Laboratories) and PBS on microscope slides. Microwell slides
were maintained in sterile PBS. HepG2 (ATCC HB-8065) cells
were seeded at 2500 cells in each well of a Microwell slide
(Hamamatsu A10657-01) in DMEM supplemented with 10%
(v/v) FCS and 2 mM L-glutamine. For lipid analysis, 24 h post
seeding cells were incubated overnight with BSA conjugated
oleic, linoleic or α-linolenic acids at 47 μg/mL. For lipidosis/
phospholipidosis screening, 24 h postseeding cells were
incubated overnight in media containing 20 μM propranolol,
10 μM chlorpromazine, 30 μM chloroquine, 10 μM tamoxifen,
0.1% (v/v) deionized water, 1% (v/v) ethanol or full media,
with (wells C1−C7) or without (A1−A7 and B1−B7) a
supplement of 9.4 μg/mL BSA conjugated Oleic acid (Sigma).
Note that the LipidTOX phospholipidosis and steatosis
detection kit is the current standard for high-throughput
imaging, as shown in ref 19, where all phospholipidosis
inducers used in our study were identiﬁed with this kit, and
conﬁrmed by comparison with electron microscopy.
■ RESULTS AND DISCUSSION
Bessel Beam Generation and Characterization. A
focused Bessel beam can provide a nonlinear probe volume
with an axial extension encompassing the full thickness of a 2D
cell culture in a multiwell plate (i.e., several microns), while
retaining high conﬁnement in-plane, thus enabling the sample’s
lateral organization to be probed at high resolution while
averaging axially for fast acquisition.
Bessel beams have been recently proposed as a way to
achieve rapid volumetric imaging via extended depth of ﬁeld in
nonlinear microscopy based on two-photon ﬂuorescence,20,21
second harmonic generation contrast,22 and single-frequency
stimulated Raman scattering.23 However, their implementation
for high-throughput hyperspectral CARS microscopy has not
yet been shown. Interestingly, their opposite use was discussed
in ref.24,25 to retrieve the axial structure of a laterally
homogeneous sample from phase matching considerations
and the directionality of the CARS emission.
Figure 2. Quantitative unsupervised retrieval of chemical components from label-free hyperspectral CARS in HeLa cells; comparison between
Gaussian and Bessel beam. Top right: Sketch of the quantitative data analysis pipeline, comprising denoising, ﬁeld retrieval, and factorization of
susceptibility spectra into independently varying chemical components and their volume concentrations. Top left: Spectra and concentration maps of
the dry components corresponding to proteins and lipids. Dashed lines are spectral proﬁles of the CARS susceptibility imaginary part. Solid lines
show the spectra after subtracting the water component. Gray scales are vol/vol concentrations between 0 (black) and M (white) indicated for each
panel. The top four images are the xz and xy concentration maps obtained by imaging the cells with Gaussian beam excitation. The yellow dashed
lines indicate the position of the cuts. The weighted average 2D projection of these 3D data is shown for the lipid component in the bottom (center),
and compared with a single in-plane image acquired with Bessel beam excitation (bottom right). Bottom left shows a diﬀerential interference
contrast image (DIC) of the same region. Acquisition settings: 0.175 μm lateral pixel size, 5 cm−1 step size, 0.01 ms pixel dwell time, for Gaussian
beam excitation 9 axial steps with 1.3 μm step size. 1× tube lens. Pump (Stokes) power onto the sample was 44 mW (24 mW) for Gaussian beam
excitation and 99 mW (50 mW) for Bessel beam excitation. Time per hyperspectral 2D image (241 spectral points) is 196 s.
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Most experimental implementations reported use a liquid
crystal phase shaper array to create the Bessel beam.22 This
method is very ﬂexible, as Bessel beams of diﬀerent cone angle
can be created, but is also rather lossy (60% transmission was
reported22 at 840 nm), complex, costly, and requires active
control. We have opted here for a simple solution using a single
axicon (instead of two in refs 24 and 25) to create the Bessel
beam, which allows for high transmission (>90% over a broad
wavelength range of 650−1100 nm) and passive stability. Three
simple elements (an aperture, an axicon, and a lens) are
mounted on ﬂip mounts, so that they can be easily switched in
and out of the beam path, allowing access to both the Gaussian
and Bessel beam excitation without realignment (see Figure 1a
and Methods).
The lateral intensity distribution in the central plane of the
Bessel beam after the axicon has the typical Bessel-beam shape
with a sharp central maximum surrounded by rings of intensity
decaying with the inverse of the radius (see Figures 1a and S1).
The axial intensity distribution at the sample is also shown in
Figure 1a. While the Gaussian beam has a short depth of ﬁeld of
about 3.5 μm, the Bessel beam has an axial extension of about
10 μm, resulting in an extended depth of ﬁeld. The addition of
the aperture results in a top-hat shape of the intensity, and
provides a better deﬁned extension of the Bessel beam (see also
Figure S2). This is speciﬁcally important for CARS since the
Figure 3. Label-free markers of phospholipidosis and neutral lipid accumulation. HeLa cells grown in media supplemented with oleic acid were
compared with HeLa cells exposed to the phospholipidosis inducer propranolol. The top two rows show HeLa cells ﬂuorescently labeled with the
phospholipid probe LipidTOX Red (red) and the neutral lipid probe LipidTOX Green (green), imaged by DIC (left) and wide-ﬁeld epiﬂuorescence.
Each ﬂuorescence channel is shown in black and white and as red-green overlay. The bottom rows show nominally identical unstained Hela cells
with the concentration maps and spectra of the lipid components retrieved from the analysis of hyperspectral CARS imaging. Concentration maps
are given in black and white on the indicated scale, and color coded as red-green overlay to exemplify the similarity with the lipid staining (red:
phospholipidosis component, green: neutral lipid components; spectra as indicated). CARS acquisition settings: 0.122 μm lateral pixel size, 5 cm−1
step size, 0.01 ms pixel dwell time. 1.5× tube lens. Pump (Stokes) power onto the sample was 53 mW (27 mW). Time per hyperspectral image (241
spectral points) is 1620 s.
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measured chemical composition is an average material response
over the Bessel beam axial extension. Note that for the
thickness of the 2D cell culture investigated by us (see
following sections), this axial extension is optimally designed.
Further extension of the Bessel beam depth would only add
unwanted volume and in turn CARS background.
Figure 1b and c shows the comparison between hyper-
spectral CARS imaging acquired with Bessel and Gaussian
beam excitation on a polystyrene bead of 1 μm nominal size in
aqueous environment (2% agarose gel). Data were analyzed
using our previously developed quantitative data analysis
pipeline (called FSC3 method).14,15,17 This analysis enables us
to retrieve the CARS susceptibility spectrum, which is linear in
the concentration of chemical components, and factorizes it
into independently varying chemical components and their
volume concentrations (see sketch in Figure 2 and Supporting
Information). Typical vol/vol concentration errors of the
retrieval are 1% absolute and 10% relative.17 Results in Figure
1b,c are shown as retrieved concentration maps (xy focal plane
and xz equatorial-axial) of the polystyrene component (vol/
vol) with corresponding line cuts, and spectral proﬁles of the
CARS susceptibility. Solid lines show the spectra of ’dry’
polystyrene, after subtracting the water component which is
present in the focal volume. The concentration maps exemplify
the elongated axial distribution, as expected, for Bessel beam
excitation, without degradation of the lateral resolution
compared to Gaussian beam excitation. The spectral proﬁle
of polystyrene measured with Bessel beam exhibits the same
vibrational resonances as with Gaussian beam excitation, the
only diﬀerence being a relatively larger water content in the
extended focal volume.
Label-Free Cell Imaging: Bessel Beam versus Gaus-
sian Beam. Figure 2 demonstrates the ability of CARS Bessel
beam excitation to provide a chemically resolved map of the
lipid distribution in HeLa cells through a single in-plane
acquisition, equivalent to an axially averaged z-stack acquisition
Figure 4. Sparse sampling with Bessel beam for high speed chemical analysis. Top: Sketch of the Sparse sampling (SS) acquisition combining a
CARS image acquired over a small number of spectral points (i.e., vibrational frequencies ωi) and a large number of spatial points (to fully resolve
the spatial features of interest), with a hyperspectral image measured on a sparse set of spatial positions over a large number of spectral points (to
fully resolve the vibrational resonances of interest). Scale bar: 20 μm. Bottom: CARS susceptibility spectrum for the lipid component in HepG2 cells
grown in media supplemented with monounsaturated oleic acid (OA), biunsaturated linoleic acid and triunsaturated α-linolenic acid (red line, SS;
black line, Full spectral and spatial (FS)). Ratio of integrated spectra in the regions indicated by the dotted lines are also shown (R2 = I2/I1 and R3 =
I3/I1). The error bar indicate the standard deviation obtained by performing 10 repetitions of the FSC
3 as an indication of the repeatability of the
analysis. FS acquisition settings: 0.122 μm lateral pixel size, 5 cm−1 step size. SS acquisition settings: 5 cm−1 step size and pixel size 0.365 μm for data
with full spectral information; ∼30 cm−1 step size and pixel size 0.122 μm for data with full spatial information. Number of spectral and spatial points
s = 21, S = 241, p = 274 × 329, P = 820 × 983. Pixel dwell time 0.01 ms. 1.5× tube lens. Pump (Stokes) power onto the sample ∼30 mW (18 mW).
Time per image in SS is (s × P + p × S) ms = 386 s, and in FS is S × P × 0.01 ms = 1942 s.
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over 9 planes with a Gaussian beam. Cells were prepared as
detailed in the Methods. The same region was imaged with
Gaussian beam and with Bessel beam, and the resulting
quantitative chemical analysis of the lipid component is shown.
As mentioned, data were analyzed using our previously
developed data analysis FSC3 algorithm, the main steps of
which are schematically shown in Figure 2 and described in the
Supporting Information. As a result of this analysis, Figure 2
shows the concentration maps and CARS susceptibility spectra
of the FSC3 components corresponding to proteins and lipids.
The top four images are the xz and xy concentration maps
obtained by imaging the cells with Gaussian beam excitation.
The weighted average 2D projection of these 3D data (using as
weight the axial proﬁle of the Bessel beam, see Supporting
Information) is shown in the bottom of Figure 2, and compared
with a single in-plane image acquired with Bessel beam
excitation. The spatial distribution of lipid droplets is equally
resolved in both images, demonstrating the ability of Bessel
beam excitation to reduce image acquisition without losing
information on lateral organization, by z-averaging over the
entire cell height in a single scan.
Note that the power density used for Bessel beam excitation
in Figure 2 is comparable with that used for live cell imaging in
ref 13. where we observed human stem cells diﬀerentiating into
adipocytes over a time course of 9 days, with no apparent
damage, arrest or cell death. This is because the peak intensity
in the central area for Bessel beam excitation is three times
lower than in a Gaussian beam for the same beam power due
to the presence of lateral rings in the Bessel beam, as shown in
Figure S1.
Label-Free Markers of Phospholipidosis. Using the
quantitative unsupervised retrieval of chemical components
from hyperspectral CARS imaging in HeLa cells under Bessel
beam illumination, we then addressed the capability of the
method to derive components able to distinguish phospholi-
pidosis from neutral lipid accumulation. HeLa cells grown in
media supplemented with oleic acid (OA) were used as positive
control for neutral lipid accumulation and compared with HeLa
cells exposed to the drug propranolol, a well-known
phospholipidosis inducer.19,26 An unsupervised FSC3 analysis
was performed on cells in propranolol to derive a “phospholipid
component” spectrum. Similarly, an unsupervised analysis was
performed on cells in OA supplemented media to derive a
“neutral lipid component” spectrum. These two spectra were
then used as guides in the combined FSC3 analysis on both
image sets together to ﬁnalize the two lipid components (see
also Supporting Information). For validation and comparison,
nominally identical cells were stained with the red dye
LipidTOX Red, which is a marker for phospholipidosis, and
the green dye LipidTOX Green neutral lipid stain which
associates with neutral lipid droplets, and were imaged with epi-
ﬂuorescence as well as diﬀerential interference contrast. The
results are summarized in Figure 3. The neutral lipid
component correlates well with the green dye staining,
markedly present in cells grown in OA supplemented media
(notably this component is absent for cells with propranolol).
Similarly, the phospholipid component correlates well with the
red staining, which is much more pronounced in cells subjected
to propranolol. Note that these components were distinct from
the protein component which was retrieved as well, in the same
combined analysis, and is shown in Figure S3.
Sparse Sampling with Bessel Beam. We recently
demonstrated a method based on sparse sampling to increase
the acquisition speed in sequential hyperspectral CARS imaging
while retaining the relevant spectral and spatial informa-
tion.14,27 Here we show that this method can be utilized
together with Bessel beam excitation, to correctly distinguish
changes in lipid chemical proﬁles inside cells, as a prerequisite
toward a fast screening platform for drug induced lipid storage.
For demonstration, we investigated HepG2 cells grown in
media supplemented with either monounsaturated oleic acid,
biunsaturated linoleic acid or triunsaturated α-linolenic acid
(see Methods) to drive systematic changes in the degree of
unsaturated neutral lipid content.13,28 For comparison, the
same cell containing regions were imaged with full spectral and
spatial resolution (FS), as well as sparse sampling (SS)
acquisition. Typically about 16 cells per sample with a given
supplemented medium were imaged and analyzed.
The SS acquisition is brieﬂy sketched in Figure 4 (top). The
method consists of combining a CARS image acquired over a
small number (s) of spectral points (i.e., vibrational frequencies
ωi) and a large number (P) of spatial points (to fully resolve the
spatial features of interest), with a hyperspectral image
measured on a small number (p) of spatial positions over a
large number (S) of spectral points (to fully resolve the
vibrational resonances of interest). For the results shown here,
the spectral points for sparse sampling acquisition were taken as
equidistantly spaced over the full spectral range, which is a
simple and close to optimal choice as discussed in ref 27. A
reconstruction algorithm (see Supporting Information) is then
applied to generate the full information as if an image with S
spectral points and P spatial points was acquired. The method,
therefore, reduces the acquisition time to a fraction (sP + Sp)/
(SP) = s/S + p/P.
Data acquired with FS, as well as SS reconstructed data, were
then analyzed with our FSC3 algorithm (as discussed for Figure
2 and in the Supporting Information). The corresponding
CARS susceptibility spectrum for the lipid component is shown
in Figure 4 (bottom). The comparison shows that SS retains
the relevant spectral information on a FS acquisition, and
importantly is able to diﬀerentiate between changes in lipid
compositions. To further exemplify this point we calculated the
integrals of the spectra in the range 2895−2980 cm−1 (I2) and
2985−3025 cm−1 (I3) and divided them by the integral of the
spectra between 2800 and 2890 cm−1 (I1; see dotted lines in
Figure 2). The corresponding ratios R2 = I2/I1 and R3 = I3/I1
are shown in Figure 4 (bottom). The error bar indicates the
standard deviation obtained by performing 10 repetitions of the
FSC3 as a measure of the repeatability of the analysis (see also
Figure S4). The characteristic vibrational bands of neutral lipids
include the peak at around 2850 cm−1 which originates from
the CH2 symmetric stretch vibrational resonance, the broad
shoulder at around 2930 cm−1 which is a combination of CH3
stretch vibrations and CH2 asymmetric stretch enhanced by the
broadening and shift of the CH deformations in the liquid
phase, and theCH stretch which gives rise to a band around
3010 cm−1.29 Therefore, the ratio R2 between the band at
around 2930 cm−1 and the CH2 symmetric stretch resonance at
2850 cm−1 can be used as a measure of disorder, which usually
correlates with the degree of unsaturation.13,28 The ratio R3 of
the 3010 cm−1 peak relative to 2850 cm−1 is a good direct
measure of the degree of unsaturation.13,28 We observe that
data acquired with SS consistently provide very similar spectral
proﬁles as with FS, and resolve the spectral diﬀerences
characteristic of an increase in the degree of fatty-acid
unsaturation (i.e., increase in R2 and R3) when the cells are
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grown in media supplemented with unsaturated fatty acids
compared to standard medium (control), with R3 showing a
systematic increase when going from monounsaturated (OA)
to triunsaturated (α-linolenic) fatty-acid supplement. Spectral
cross-correlations of these lipid components are shown in the
Table S1. We ﬁnd that, for the same component, the spectrum
acquired with SS diﬀers from the one acquired with FS by less
than 0.75% on average. Notably, diﬀerences between lipid
components are small in the cross-correlations (2% to 3%, see
Table S1) as these provide an integrated spectral information.
The analysis of the ratios R2 and R3 between bands gives a
better spectral separation between components, and shows that
SS resolves the same relative bands as FS. The concentration
maps of the lipids retrieved using SS or FS are also very similar,
as shown in the Figure S5.
It is also worth pointing out that in ref 13. we compared the
outcome of the FSC3 analysis between measuring in the CH-
stretch vibrational range versus the ﬁngerprint region, and
found consistent results in terms of sensitivity to changes in
lipid chemical proﬁles inside cells. This is because the reduction
in spectral separation when analyzing the congested CH-stretch
region is compensated by the improved signal-to-noise ratio
due to the higher CARS susceptibility in this vibrational range.
Screening for Drug-Induced Lipid Storage. Finally, we
merged the ability to identify label-free markers of phospho-
lipidosis via hyperspectral CARS (as shown in Figure 3) with
the fast acquisition provided by Bessel beam excitation and
Figure 5. Example of screening for drug-induced lipid storage using hyperspectral CARS with Bessel beam excitation and sparse sampling
acquisition. HepG2 cells were treated with various combinations of phospholipidosis and neutral lipid accumulation inducers in a multiwell slide.
Panel a shows HepG2 cells in well B3 treated with the phospholipidosis inducer chlorpromazine, imaged by DIC and hyperspectral CARS resulting
in factorized lipid spectra and concentration components. Concentration maps are given from 0 (black) to maximum M (white) vol/vol
concentration, as indicated, and as red-green overlay (red, phospholipid component; green, neutral lipid component). Panels b and c show the
outcomes of three binary classiﬁers using a SVM discriminative algorithm (see text). Panel c gives the results of each binary classiﬁcation
(phospholipidosis (P) versus steatosis (S), phospholipidosis versus control (C), and steatosis versus control), with training sets labeled by the star
symbol. Panel b shows the results in a triangular-distance diagram; each well is color coded (as per table in c) and is plotted using the distances for
each classiﬁer times unit vectors: + + −d d d(1,0) (1/2, 3 /2) ( 1/2, 3 /2)SP CP CS. The unit vectors are indicated as (1,0) solid, (1/2, 3 /2)
dashed and (−1/2, 3 /2) dotted. SS acquisition settings: 5 cm−1 step size and pixel size 0.365 μm for data with full spectral information; 60 cm−1
step size and pixel size 0.122 μm for data with full spatial information; number of spectral and spatial points s = 21, S = 241, p = 274 × 329, P = 820
× 983. Pixel dwell time 0.01 ms. 1.5× tube lens. Pump (Stokes) power onto the sample 37 mW (22 mW). Time per image in SS is 386 s.
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sparse sampling (45× faster than Gaussian beam illumination
and full spectral acquisition for the settings used here), in order
to screen a group of known and putative phospholipidosis
inducers. Human HepG2 liver cells were treated with various
combinations of compounds in a multiwell slide and then ﬁxed
(see Methods). First, two spectral components were identiﬁed
in a similar way a described in the previous section about label-
free markers for phospholipidosis, using cells treated with
Chloroquine as a known inducer for phospholipidosis30 and
cells grown in medium supplemented with OA as positive
control for neutral lipid droplet formation. These spectra were
then used as guides in the FSC3 analysis; images from all wells
were analyzed as one set, to pull out common spectra and
compare the concentration of these chemical components
across the group (see Supporting Information). Figure 5a
shows the spectra and concentration maps for the well B3
(chlorpromazine) for the two lipid components, which
associate with phospholipidosis (red spectrum) and neutral
lipid accumulation (green spectrum). The protein component
which was retrieved in the same combined analysis is shown in
the Figure S6.
We then tested if the high-content capability of the
hyperspectral CARS analysis could be used to derive a set of
predictors to train a support vector machine (SVM)
discriminative algorithm and in turn classify the drug responses
in terms of neutral lipid accumulation (steatosis) versus
phospholipidosis in a completely label-free assay. From the
pixel-by-pixel distribution of the protein and lipids concen-
tration maps we extracted the mean value, the standard
deviation, the skewness, the kurtosis, and the spatial correlation
radius. Additionally, the mean values of the normalized spatial
cross-correlations between the three components are included
(see Supporting Information). This resulted in a total of 18
predictors per well/sample (typically ∼30 cells were imaged
and analyzed per well).
The calculated predictors are used to train a linear SVM
model for two-class (binary) classiﬁcation. To discriminate
phospholipidosis (P) from steatosis (S) and control (C) cases,
we performed three binary classiﬁcations: P versus S, P versus
C and S versus C. For the training sets, we use the predictors
obtained from the images of the wells containing cells treated
with Chloroquine (for P), medium supplemented with OA (for
S), and standard medium (for C). Figure 5c gives a table of all
the wells, and indicates the training sets labeled as stars (the
sample unit is the entire image per well, i.e., ∼30 cells).
Concentration maps for the wells used as training sets are given
in Figure S8. The classiﬁcation algorithm returns a hyperplane,
and the normalized distance from it gives a measurement of the
aﬃnity with one of the two groups. To reduce the
dimensionality of the predictor space, we trained each classiﬁer
with all possible subsets of the 18 predictors and selected the
subset which was minimizing a ﬁgure of merit deﬁned as
detailed in the Supporting Information.
After training the classiﬁers, we calculated the normalized
distance d from the hyperplane for the wells not included in the
training sets. The results of the classiﬁcation analysis are shown
for each binary classiﬁcation in Figure 5c, and as an overview
triangular-distance diagram in Figure 5b. We ﬁnd that
chlorpromazine and tamoxifen are classiﬁed as phospholipidosis
inducers, consistent with previous studies.19,31 Notably, the
combinations of chlorpromazine with OA and tamoxifen with
OA are not classiﬁed as phospholipidosis inducer, suggesting
that the addition of OA is able to aﬀect the drug-induced
phospholipidosis in these cases. Conversely, chloroquine with
OA is still classiﬁed as phospholipidosis inducer. Compound-
free wells containing cells grown in standard media (with or
without addition of the solvents used for the drugs) are all
classiﬁed as control cases, as expected.
■ CONCLUSIONS
We have combined Bessel beam illumination with sparse
sampling acquisition in hyperspectral CARS imaging for the
ﬁrst time, which enabled us to perform label-free high-content
microscopy-based screening. For the setting used here, we
show a 45-fold increase in speed (9-fold increase from the
Bessel beam illumination compared to Gaussian beam
excitation and 5-fold increase from sparse sampling compared
to full spatial and spectral acquisition). This could be further
increased by an even sparser sampling acquisition, eventually
limited by the number of relevant spectral components and the
signal-to-noise ratio. For example, in ref 27. we demonstrated
sparse sampling with a reduction in the acquisition time by a
factor of 25, which, if combined with the Bessel beam
illumination shown here, would lead to 225-fold increase in
acquisition speed, making CARS imaging within a 384-well
format (the most frequently used for high-throughput screen-
ing) achievable. The Bessel beam illumination shown here was
optimized to provide a probe volume with an axial extension
encompassing the full thickness of the 2D cell culture while
retaining high conﬁnement in-plane, thus enabling the sample’s
lateral organization to be probed at high resolution and
averaging axially for fast acquisition. While further extension of
the Bessel beam would only add unwanted volume in this case,
it is practically possible, and might be desirable for thicker
samples.
Hyperspectral CARS images were analyzed using our
quantitative data analysis pipeline which retrieves Raman-like
susceptibility spectra and factorizes them into water, proteins
and lipid chemical components with associated concentration
maps in vol/vol units. By examining cells subjected to known
phospholipidosis inducers as well as cells in media
supplemented with oleic acid, two chemical components were
identiﬁed as label-free markers for phospholipidosis and
steatosis (neutral lipid accumulation), in good agreement
with state-of-the art ﬂuorescence staining.
We screened 15 combinations of drugs and neutral lipids
added to human HepG2 liver cells in a multiwell slide. From
the pixel-by-pixel statistical distribution of the protein and lipids
concentration maps and the normalized spatial cross-
correlations between the components within the cells, we
extracted 18 predictors per well/sample. The calculated
predictors were used to train three support vector machine
binary discriminative algorithms which classiﬁed the drug
responses in terms of steatosis versus phospholipidosis, control
versus phospholipidosis, and control versus steatosis.
Although shown here for drug induced lipid storage within
hepatic tissue, Bessel-beam hyperspectral CARS microscopy
with sparse sampling is a general platform for label-free high-
content high-throughput quantitative chemical imaging. An
area where it will be of speciﬁc interest, is for research into
Nonalcoholic fatty liver disease, a condition that can aﬀect up
to 30% of the adult population, is found in 80% of obese and
diabetic patients and can lead to liver cirrhosis if left
unchecked.32,33 There are currently no approved pharmaco-
logical treatments for Nonalcoholic fatty liver disease, and
recent small molecule screens have utilized triglyceride
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colorimetry assays to identify compounds that reduce lipid
storage within primary hepatocytes,32 but can give no
indication on the chemical composition of lipid storage during
treatment. The high throughput hyperspectral analysis outlined
within this paper would provide information as to how the lipid
composition is changing within these cells, while also providing
readout information on cell health indicators (such as
phospholipidosis).
For cell models that are particularly diﬃcult/impossible to
stain within live assays, such as embryonic stem cells,
mammalian eggs and embryos, this technique oﬀers a solution
to observe multiple chemical parameters in order to understand
fundamental questions in cell biology through the label-free
screening of phenotypes. It is also compatible and can run
alongside ﬂuorescent assays, allowing chemical proﬁling of cell
populations while screening through classical ﬂuorescent based
imaging techniques, enabling multiparametric assessment with
chemical sensitivity.
Notably, the application of this technology goes beyond its
use in cell assays. The recent use of CARS in identifying
atherosclerotic34 and amyloid35 plaques opens up the prospect
of implementing our method for quantitative chemical
imaging/screening of tissue sections to identify regions of
disease in an automated noninvasive label-free manner with
content and throughput as yet unseen.
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